Stay updated on Pembrolizumab in Glioblastoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Glioblastoma Clinical Trial page.

Latest updates to the Pembrolizumab in Glioblastoma Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.2%
- Check18 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference1%
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page has updated its status to 'Completed' and added specific dates for upcoming events in May 2025, while removing outdated information regarding previous statuses and estimated dates.SummaryDifference1%
- Check39 days agoChange DetectedDifference0.1%
- Check46 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.2%
- Check61 days agoChange DetectedThe page has undergone significant updates, including the removal of detailed descriptions of a clinical trial for glioblastoma and the addition of new identifiers and a location for the study. The revision number has also been updated.SummaryDifference62%
Stay in the know with updates to Pembrolizumab in Glioblastoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Glioblastoma Clinical Trial page.